Park J H, Kumar R, Davis P L. "一种的合成方法" [P]. US Patent, US 10752135 B2, 2020-01-02.
Sørensen M, Schröder R, Jørgensen K. "Method for the Synthesis of (9α,10α,13α,14α)-17-Methyl-morphinan-3,10-diol" [P]. European Patent, EP 3477545 A1, 2016-06-01.
发明人张德明,胡光,马晓峰. "A Process for Preparing High-Purity (9α,10α,13α,14α)-17-Methyl-morphinan-3,10-diol" [P]. 中国发明专利, 专利号 CN 116226687 A, 授权公告日 2025-03-25.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2019, 312, (7), 6200-6205.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2011, 1065, 9384-9414.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of (9α,10α,13α,14α)-17-Methyl-morphinan-3,10-diol Using HRMS and NMR". Anal. Chem., 2010, 1486, 7054-7063.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2014, 1534, 26-30.